Irisin: a new molecular marker and target in metabolic disorder

Table 2 Level of irisin in other pathological condistions

Pathological conditions	Level of irisin	Reference
Newly diagnosed T2DM	Decrease	Choi et al. [11] Xiang et al. [21] Kurdiova et al. [22]
Long-term T2DM	Decrease	Liu et al. [6] Moreno-Navarrete et al. [10] Zhang et al. [23]
GDM	Decrease	Yuksel et al. [24] Kuzmicki et al. [25]
GDM	No difference	Ebert et al. [26]
MetS	Increase	Hee et al. [16]
MetS	Decrease	Yan et al. [17]
NAFLD	Decrease	Zhang et al. [34] Polyzos et al. [35]
NAFLD	Increase	Choi et al. [36]
PCOS	Increase	Chang et al. [37]
CKD	Decrease	Liu et al. [7] Wen et al. [38] Ebert et al. [39]

ISSN: 1476-511X